Variant report

Variant	esv2762522
Chromosome Location	chr17:19976462-19996429
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:173)
CpG islands
(count:674)
Chromatin interactive
region (count:17)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:173 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr17:19989720-19989944	K562	blood:	n/a	n/a
2	BACH1	chr17:19992466-19992473	K562	blood:	n/a	n/a
3	BACH1	chr17:19993580-19993597	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr17:19981399-19981679	GM12878	blood:	n/a	n/a
5	BHLHE40	chr17:19977155-19977165	K562	blood:	n/a	n/a
6	CEBPB	chr17:19986811-19987160	IMR90	lung:	n/a	n/a
7	CEBPB	chr17:19977475-19977675	HepG2	liver:	n/a	n/a
8	CEBPB	chr17:19977397-19977746	A549	lung:	n/a	n/a
9	CEBPB	chr17:19986566-19987181	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr17:19977406-19977677	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr17:19977414-19977730	IMR90	lung:	n/a	n/a
12	CEBPB	chr17:19976727-19977036	K562	blood:	n/a	n/a
13	CEBPB	chr17:19986818-19987165	A549	lung:	n/a	n/a
14	CEBPB	chr17:19986864-19987129	HepG2	liver:	n/a	n/a
15	CEBPB	chr17:19986772-19987297	A549	lung:	n/a	n/a
16	CTCF	chr17:19988687-19988695	GM19238	blood:	n/a	n/a
17	CTCF	chr17:19988600-19988750	HAc	cerebellar:	n/a	n/a
18	CTCF	chr17:19988500-19988650	GM12871	blood:	n/a	n/a
19	CTCF	chr17:19977494-19977546	ProgFib	skin:	n/a	n/a
20	CTCF	chr17:19988580-19988730	WERI-Rb-1	eye:	n/a	n/a
21	CTCF	chr17:19988613-19988742	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr17:19989725-19989937	MCF-7	breast:	n/a	chr17:19989803-19989812
23	CTCF	chr17:19988580-19988730	GM12864	blood:	n/a	n/a
24	CTCF	chr17:19989800-19989950	Hela-S3	cervix:	n/a	chr17:19989803-19989812
25	CTCF	chr17:19989728-19989950	MCF-7	breast:	n/a	chr17:19989803-19989812
26	CTCF	chr17:19988580-19988730	GM12874	blood:	n/a	n/a
27	CTCF	chr17:19989771-19989909	K562	blood:	n/a	chr17:19989803-19989812
28	CTCF	chr17:19989760-19989910	SK-N-SH_RA	brain:	n/a	chr17:19989803-19989812
29	CTCF	chr17:19989563-19990029	MCF-7	breast:	n/a	chr17:19989803-19989812
30	CTCF	chr17:19989680-19989830	GM12875	blood:	n/a	chr17:19989803-19989812
31	CTCF	chr17:19989702-19989952	MCF-7	breast:	n/a	chr17:19989803-19989812
32	CTCF	chr17:19988340-19988490	GM12872	blood:	n/a	n/a
33	CTCF	chr17:19989829-19989846	GM10266	blood:	n/a	n/a
34	CTCF	chr17:19989760-19989910	NB4	blood:	n/a	chr17:19989803-19989812
35	CTCF	chr17:19988580-19988730	HepG2	liver:	n/a	n/a
36	CTCF	chr17:19989680-19989966	MCF-7	breast:	n/a	chr17:19989803-19989812
37	CTCF	chr17:19988620-19988770	GM12875	blood:	n/a	n/a
38	CTCF	chr17:19989680-19989830	K562	blood:	n/a	chr17:19989803-19989812
39	CTCF	chr17:19989779-19989935	Hela-S3	cervix:	n/a	chr17:19989803-19989812
40	CTCF	chr17:19987837-19987954	IMR90	lung:	n/a	n/a
41	CTCF	chr17:19988660-19988810	GM12873	blood:	n/a	n/a
42	CTCF	chr17:19989720-19989947	K562	blood:	n/a	chr17:19989803-19989812
43	CTCF	chr17:19988560-19988830	GM12871	blood:	n/a	n/a
44	CTCF	chr17:19988648-19988705	Hela-S3	cervix:	n/a	n/a
45	CTCF	chr17:19988560-19988710	SK-N-SH_RA	brain:	n/a	n/a
46	CTCF	chr17:19989720-19989870	MCF-7	breast:	n/a	chr17:19989803-19989812
47	CTCF	chr17:19989740-19989890	WERI-Rb-1	eye:	n/a	chr17:19989803-19989812
48	CTCF	chr17:19988600-19988750	HRPEpiC	eye:	n/a	n/a
49	CTCF	chr17:19989766-19989776	MCF-7	breast:	n/a	n/a
50	CTCF	chr17:19988580-19988730	HEK293	kidney:	n/a	n/a

(count:674 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:19976435-19976485	MCF10A-Er-Src	breast:	n/a
2	chr17:19990302-19990352	HRE	kidney:	n/a
3	chr17:19995277-19995327	HEEpiC	esophagus:	n/a
4	chr17:19976435-19976485	MCF10A-Er-Src	breast:	n/a
5	chr17:19990302-19990352	HRE	kidney:	n/a
6	chr17:19995277-19995327	HEEpiC	esophagus:	n/a
7	chr17:19977025-19977075	HCT-116	colon:	n/a
8	chr17:19976888-19976938	BE2_C	brain:	n/a
9	chr17:19977025-19977075	AG04449	skin:	fetal
10	chr17:19995277-19995327	HIPEpiC	eye:	n/a
11	chr17:19989722-19989772	CMK	blood:	n/a
12	chr17:19976569-19976619	GM12891	blood:	n/a
13	chr17:19976569-19976619	RPTEC	kidney:	n/a
14	chr17:19977025-19977075	SK-N-SH	brain:	n/a
15	chr17:19989115-19989165	SK-N-SH	brain:	n/a
16	chr17:19976435-19976485	AoSMC	blood vessel:	n/a
17	chr17:19989722-19989772	ECC-1	luminal epithelium:	n/a
18	chr17:19989722-19989772	HCPEpiC	choroid plexus:	n/a
19	chr17:19990302-19990352	AG10803	skin:	n/a
20	chr17:19989186-19989236	RPTEC	kidney:	n/a
21	chr17:19995277-19995327	AG09309	skin:	n/a
22	chr17:19976820-19976870	LNCaP	prostate:	n/a
23	chr17:19977025-19977075	HMEC	breast:	n/a
24	chr17:19989115-19989165	PANC-1	pancreas:	n/a
25	chr17:19976435-19976485	HMEC	breast:	n/a
26	chr17:19977156-19977206	HAEpiC	amniotic membrane:	n/a
27	chr17:19976888-19976938	GM12892	blood:	n/a
28	chr17:19976435-19976485	RPTEC	kidney:	n/a
29	chr17:19989722-19989772	RPTEC	kidney:	n/a
30	chr17:19989186-19989236	Hela-S3	cervix:	n/a
31	chr17:19976820-19976870	SK-N-SH	brain:	n/a
32	chr17:19977025-19977075	Hela-S3	cervix:	n/a
33	chr17:19976569-19976619	ProgFib	skin:	n/a
34	chr17:19976435-19976485	T-47D	breast:	n/a
35	chr17:19995277-19995327	HEK293	kidney:	embryo
36	chr17:19976888-19976938	ECC-1	luminal epithelium:	n/a
37	chr17:19989186-19989236	AG10803	skin:	n/a
38	chr17:19989115-19989165	MCF10A-Er-Src	breast:	n/a
39	chr17:19977156-19977206	HPAEpiC	pulmonary alveolar:	n/a
40	chr17:19989722-19989772	AoSMC	blood vessel:	n/a
41	chr17:19977025-19977075	HAEpiC	amniotic membrane:	n/a
42	chr17:19976888-19976938	GM19239	blood:	n/a
43	chr17:19977156-19977206	RPTEC	kidney:	n/a
44	chr17:19990302-19990352	NH-A	brain:	n/a
45	chr17:19977156-19977206	GM12891	blood:	n/a
46	chr17:19989115-19989165	NHBE	bronchial:	n/a
47	chr17:19976820-19976870	GM12892	blood:	n/a
48	chr17:19977025-19977075	MCF10A-Er-Src	breast:	n/a
49	chr17:19977025-19977075	NHBE	bronchial:	n/a
50	chr17:19977025-19977075	CMK	blood:	n/a

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:19980057..19981963-chr17:19993152..19995446,2	K562	blood:
2	chr17:19993292..19995156-chr17:20055465..20057406,2	MCF-7	breast:
3	chr17:19977490..19979005-chr17:19979596..19981343,2	K562	blood:
4	chr17:19994190..19996745-chr17:20058300..20060298,2	MCF-7	breast:
5	chr17:19977490..19979191-chr17:19979596..19981343,3	K562	blood:
6	chr17:19980057..19981963-chr17:19993152..19995446,2	K562	blood:
7	chr17:19991747..19994521-chr2:209032147..209035018,4	K562	blood:
8	chr17:19937388..19940075-chr17:19983196..19985381,2	K562	blood:
9	chr17:19977490..19979005-chr17:19979596..19981343,2	K562	blood:
10	chr17:19894457..19896275-chr17:19994382..19996657,2	MCF-7	breast:
11	chr17:19995540..19998202-chr2:209032220..209035134,2	MCF-7	breast:
12	chr17:19991773..19994998-chr2:209032034..209035004,3	K562	blood:
13	chr17:19987801..19990549-chr17:19990634..19992349,2	MCF-7	breast:
14	chr17:19980691..19982440-chr17:19988864..19991537,2	K562	blood:
15	chr17:19977490..19979191-chr17:19979596..19981343,3	K562	blood:
16	chr17:19880813..19883681-chr17:19988880..19990706,2	MCF-7	breast:
17	chr17:19969588..19972096-chr17:19993265..19995045,2	K562	blood:

No data

Variant related genes	Relation type
SPECC1	TF binding region
SPECC1	CpG island
ENSG00000128487	chromatin interactions
ENSG00000108599	chromatin interactions

Extended variants
information (count: 748 )
Associated
traits (count: 152 )

Variant overlapped rSNPs/rCNVs (count:748 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs556779238	chr17:19976509-19976510	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs140460939	chr17:19976512-19976513	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs550265324	chr17:19976515-19976516	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs548853989	chr17:19976532-19976533	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs188894084	chr17:19976563-19976564	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs572411776	chr17:19976594-19976595	Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
7	rs541066641	chr17:19976608-19976609	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs560892413	chr17:19976632-19976633	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs8076660	chr17:19976770-19976771	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs112802391	chr17:19976783-19976784	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs201206075	chr17:19976785-19976786	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs374270982	chr17:19976821-19976822	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs150398645	chr17:19976829-19976830	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs532174489	chr17:19976858-19976859	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs569043749	chr17:19976885-19976886	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs145255706	chr17:19976888-19976889	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs149158123	chr17:19976899-19976900	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs565593107	chr17:19977027-19977028	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs192938938	chr17:19977082-19977083	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs548197212	chr17:19977114-19977115	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs567993765	chr17:19977145-19977146	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs536921920	chr17:19977159-19977160	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs13339684	chr17:19977211-19977212	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs371562430	chr17:19977226-19977227	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs4341795	chr17:19977228-19977229	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs559057529	chr17:19977236-19977237	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs555707390	chr17:19977249-19977250	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs572440509	chr17:19977354-19977355	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs533822570	chr17:19977379-19977380	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs182794134	chr17:19977398-19977399	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs4346259	chr17:19977414-19977415	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs538335551	chr17:19977454-19977455	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs574464292	chr17:19977459-19977460	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs137983764	chr17:19977467-19977468	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs563202774	chr17:19977493-19977494	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs532339357	chr17:19977501-19977502	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs116650071	chr17:19977505-19977506	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs187299242	chr17:19977540-19977541	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs528158820	chr17:19977568-19977569	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs73984568	chr17:19977614-19977615	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs568082624	chr17:19977618-19977619	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs376804958	chr17:19977696-19977697	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs369880295	chr17:19977833-19977834	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs12949710	chr17:19977838-19977839	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs540135816	chr17:19977854-19977855	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs570204159	chr17:19977933-19977934	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs539262592	chr17:19978007-19978008	Flanking Active TSS Active TSS Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs386796041	chr17:19978017-19978018	Flanking Active TSS Active TSS Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs114050000	chr17:19978019-19978020	Flanking Active TSS Active TSS Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs16960672	chr17:19978028-19978029	Flanking Active TSS Active TSS Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:152)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Autism	22543975	CNVD
Sezary syndrome	18413736	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:607 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:19968000-19977000	Weak transcription	Duodenum Mucosa	Duodenum
2	chr17:19968200-19977000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr17:19969200-19976600	Weak transcription	Aorta	Aorta
4	chr17:19974200-19978000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr17:19975000-19976600	Enhancers	Primary monocytes fromperipheralblood	blood
6	chr17:19975200-19976600	Enhancers	Brain Hippocampus Middle	brain
7	chr17:19975200-19976600	Enhancers	Brain Inferior Temporal Lobe	brain
8	chr17:19975200-19976600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
9	chr17:19975200-19976800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr17:19975200-19977000	Enhancers	Brain Cingulate Gyrus	brain
11	chr17:19975200-19977000	Enhancers	Ovary	ovary
12	chr17:19975200-19977600	Enhancers	K562	blood
13	chr17:19975400-19976600	Enhancers	Brain Anterior Caudate	brain
14	chr17:19975400-19976800	Enhancers	Fetal Thymus	thymus
15	chr17:19975400-19977000	Enhancers	Brain Substantia Nigra	brain
16	chr17:19975400-19978000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr17:19975400-19978800	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
18	chr17:19975600-19976600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr17:19975600-19976600	Enhancers	Adipose Nuclei	Adipose
20	chr17:19975600-19976600	Enhancers	Skeletal Muscle Male	skeletal muscle
21	chr17:19975600-19976800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
22	chr17:19975600-19976800	Enhancers	Fetal Muscle Leg	muscle
23	chr17:19975600-19976800	Enhancers	Skeletal Muscle Female	skeletal muscle
24	chr17:19975600-19977200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr17:19975600-19977600	Enhancers	Brain Germinal Matrix	brain
26	chr17:19975800-19976800	Enhancers	Brain Angular Gyrus	brain
27	chr17:19975800-19977000	Enhancers	Fetal Muscle Trunk	muscle
28	chr17:19975800-19977200	Enhancers	A549	lung
29	chr17:19975800-19977600	Enhancers	Cortex derived primary cultured neurospheres	brain
30	chr17:19975800-19978000	Enhancers	NHDF-Ad	bronchial
31	chr17:19975800-19978200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
32	chr17:19976000-19976600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
33	chr17:19976000-19976600	Enhancers	Primary T helper cells fromperipheralblood	blood
34	chr17:19976000-19976600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
35	chr17:19976000-19976800	Enhancers	Primary B cells from peripheral blood	blood
36	chr17:19976000-19976800	Weak transcription	Esophagus	oesophagus
37	chr17:19976000-19977000	Weak transcription	Left Ventricle	heart
38	chr17:19976000-19977000	Weak transcription	Rectal Mucosa Donor 31	rectum
39	chr17:19976000-19977000	Weak transcription	Right Atrium	heart
40	chr17:19976000-19977000	Weak transcription	Right Ventricle	heart
41	chr17:19976000-19978200	Flanking Active TSS	Primary hematopoietic stem cells	blood
42	chr17:19976000-19978200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr17:19976200-19976600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr17:19976200-19976600	Enhancers	Duodenum Smooth Muscle	Duodenum
45	chr17:19976200-19977000	Enhancers	Primary T helper naive cells from peripheral blood	blood
46	chr17:19976200-19977000	Enhancers	Primary T killer memory cells from peripheral blood	blood
47	chr17:19976200-19977800	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr17:19976200-19978000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
49	chr17:19976200-19978200	Flanking Active TSS	Primary T cells from cord blood	blood
50	chr17:19976200-19988000	Weak transcription	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links